Adaptimmune Therapeutics PLC (ADAP)
0.82
+0.01
(+0.64%)
USD |
NASDAQ |
Nov 05, 09:33
Adaptimmune Therapeutics EPS Estimates for Current Fiscal Year
EPS Estimates for Current Fiscal Year Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Estimates for Current Fiscal Year Data
| Date | Value |
|---|---|
| August 12, 2024 | -- |
| August 02, 2024 | -- |
| June 12, 2024 | -- |
| May 31, 2024 | -- |
| May 30, 2024 | -- |
| May 15, 2024 | -- |
| March 06, 2024 | -- |
| January 04, 2024 | -- |
| December 31, 2023 | -- |
| November 09, 2023 | -- |
| November 08, 2023 | -- |
| August 14, 2023 | -- |
| August 09, 2023 | -- |
| May 19, 2023 | -- |
| May 15, 2023 | -- |
| May 12, 2023 | -- |
| April 11, 2023 | -- |
| March 24, 2023 | -- |
| March 07, 2023 | -- |
| Date | Value |
|---|---|
| March 06, 2023 | -- |
| February 24, 2023 | -- |
| January 04, 2023 | -- |
| December 31, 2022 | -- |
| November 23, 2022 | -- |
| November 11, 2022 | -- |
| November 08, 2022 | -- |
| September 30, 2022 | -- |
| September 09, 2022 | -- |
| September 06, 2022 | -- |
| August 04, 2022 | -- |
| May 17, 2022 | -- |
| May 09, 2022 | -- |
| April 29, 2022 | -- |
| March 14, 2022 | -- |
| February 04, 2022 | -- |
| January 14, 2022 | -- |
| January 11, 2022 | -- |
Earnings Per Share Estimates Definition
This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.